Venus Concept Receives 510(k) for the Venus NOVA, Its Most Advanced Multi-Application Platform for Non-Invasive Body and Skin Treatments

Venus NOVA is supported by the Venus Jumpstart Program, a 30-day roadmap providing advanced clinical education, marketing enablement, and strategic implementation. This ensures seamless integration ...
Laweekly

Revolutionizing Brain Cancer Treatment: NeOnc Introduces First Non-Invasive Intranasal Drug Delivery for Brain Cancer

NeOnc, a biotech company helmed by Dr. Thomas Chen, brings the first non-invasive intranasal drug delivery for brain cancer into the spotlight. With this revolutionary treatment, NeOnc is poised to ...
Yahoo Finance

Non Muscle Invasive Bladder Cancer Pipeline Market Research 2025: Significant R&D Opportunities with Over 20 Companies and 22 Pipeline Drugs

Dublin, Oct. 22, 2025 (GLOBE NEWSWIRE) -- The "Non Muscle Invasive Bladder Cancer - Pipeline Insight, 2025" clinical trials has been added to ResearchAndMarkets.com's offering. This "Non Muscle ...
Morningstar

Intelligent Bio Solutions Announces Adoption of its Non-Invasive Drug Screening Solution by Global Engineering Leader, Pyrotek

Pyrotek previously conducted drug testing every three to six months, relying on an external provider to screen a limited number of employees. With INBS’ Intelligent Fingerprinting Drug Screening ...
Seeking Alpha

Intelligent Bio Solutions Showcases Rapid, Non-Invasive Drug Testing Capabilities in Remote Queensland Workforce Deployment

NEW YORK, May 19, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing ...

Mediver Selected for Ministry of SMEs and Startups' 'Deep Tech TIPS'... Accelerates Development of Non-Invasive Microcurrent-Based Electronic Drug for Pain

Mediver Co., Ltd. (CEO Yoo Seunggu), a company specializing in medical electronic drugs, has been finally selected as a recipient for the 'Deep Tech ...
Morningstar

Intelligent Bio Solutions Adds Next-Gen Wearable for Extended Drug Detection to Product Offering, Strengthening Leadership in Non-Invasive Testing

NEW YORK, July 15, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing ...
Targeted Oncology

FDA Orphan Drug Designation Granted to Exosome-Based Treatment for GBM

An exosome-based treatment of glioblastoma multiforme (GBM) has received orphan drug designation from the FDA. 1 Exousia AI, ...
Seeking Alpha

Intelligent Bio Solutions Announces Adoption of its Non-Invasive Drug Screening Solution by Global Engineering Leader, Pyrotek

NEW YORK, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company offering non-invasive, rapid testing solutions, today ...